article thumbnail

Gender-affirming surgeries tripled in the U.S. between 2016-2019, study finds

STAT

nearly tripled between 2016 and 2019, according to new national estimates from a cohort study in JAMA Network Open. Over 48,000 people got some type of gender-affirming surgery between 2016-2020, with a slight decrease in the number of surgeries performed in 2020, likely because of the pandemic.

233
233
article thumbnail

SCOTUS’ abortion pill mifepristone case is really about the FDA

STAT

The agency in 2016 extended that approval to 10 weeks and in 2021 removed the in-person dispensing requirement, citing years of data showing the drug’s relative safety. Now, in the wake of Roe v.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

STAT+: New antibiotics were underprescribed for hard-to-treat infections, study finds

STAT

They examined data spanning January 2016 through June 2021 at 619 U.S. “There is an urgent need to understand why clinicians at hospitals with access to newer agents do not always prefer newer agents,” the researchers wrote in the Annals of Internal Medicine. Continue to STAT+ to read the full story…

Hospitals 303
article thumbnail

EPA bans asbestos, a deadly carcinogen still in use decades after partial ban

STAT

The final rule marks a major expansion of EPA regulation under  a landmark 2016 law  that overhauled regulations governing tens of thousands of toxic chemicals in everyday products, from household cleaners to clothing and furniture. Read the rest…

208
208
article thumbnail

Opinion: Aduhelm was a mess — and it could happen again

STAT

In the eight years between the drug’s spectacular 2016 debut on the cover of Nature and its ignominious end , Biogen made multiple, really bad decisions. Its decision, the company explained, is not a response to new data about the drug’s safety or efficacy, but instead “a reprioritization of resources.”

349
349
article thumbnail

STAT+: Johnson & Johnson to buy Shockwave Medical for $13.1 billion

STAT

The company earned its first clearance from the Food and Drug Administration in 2016 , and went public in 2019 at a share price of $17.  According to a press statement, Shockwave has treated 400,000 patients with this method globally.

315
315
article thumbnail

Opinion: A new HHS rule rules takes a far too narrow approach to health care data interoperability

STAT

In 2016, the 21 st Century Cures Act required that the U.S. make progress toward interoperability, which it defined as “all electronically accessible health information” to be accessed, exchanged and used “without special effort on the part of the user.”

222
222